The novel HLA-C*06:372 allele, identified in a stem cell donor of an old order mennonite ethnicity
View abstract on PubMed
Summary
This summary is machine-generated.A novel Human Leukocyte Antigen C (HLA-C) allele, HLA-C*0372, has been identified. This new allele differs from a known allele, HLA-C*06:02:01:01, by a single nucleotide substitution in exon 4.
Area Of Science
- Immunogenetics
- Molecular biology
Background
- The Human Leukocyte Antigen (HLA) system plays a critical role in immune response.
- Polymorphisms within HLA genes, particularly HLA-C, contribute to immune diversity and disease susceptibility.
Purpose Of The Study
- To report the characterization of a newly identified HLA-C allele, HLA-C*0372.
- To detail the specific genetic difference between HLA-C*0372 and a previously documented allele.
Main Methods
- Sequence analysis of the HLA-C gene.
- Comparison of the novel HLA-C*0372 sequence with existing HLA allele databases.
Main Results
- A new HLA-C allele, designated HLA-C*0372, was identified.
- HLA-C*0372 is distinguished from HLA-C*06:02:01:01 by a single nucleotide substitution located in exon 4.
Conclusions
- The identification of HLA-C*0372 expands the known HLA-C allele repertoire.
- This finding contributes to a more comprehensive understanding of HLA polymorphism and its implications for immunogenetics research.
Related Concept Videos
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

